You can now read 10 articles each month for free on

The Boston Globe


Senators fault FDA on Ameridose

WASHINGTON — During the second day of congressional hearings into a fatal meningitis outbreak blamed on a Framingham pharmacy, senators said regulators not only failed to move aggressively against New England Compounding Center, but also a sister company that supplies drugs to thousands of hospitals nationwide.

As a result of a problematic 2008 inspection of Ameridose LLC, a large-scale drug compounder in Westborough, Food and Drug Administration investigators recommended that the agency issue a warning letter to the company, according to a report prepared by the staff of the Senate Committee on Health, Education, Labor, and Pensions, which held the hearing.

Loading comments...

You have reached the limit of 10 free articles a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than $1 a week